BETNOVATE OINT

IT CONTAIN 0.122 % w/w betamethasone 17-valerate 0.122% w/w .

6.90 EGP

Purchase this product now and earn 7 Points!

BETNOVATE OINT; betamethsone, dermatological agents .

ACTIVE-INGREDIENT OF BETNOVATE OINT

IT CONTAIN 0.122 % w/w betamethasone 17-valerate 0.122% w/w .

INDICATION OF BETNOVATE OINT

BETNOVATE is a potent topical corticosteriod indicated for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses . these include the following :- atopic dermatitis . – nummular dermatitis ( discoid eczema ) – prurigo nodularis .- psoriasis( excluding widespread plaque psoriasis ) .- lichen simplex chronicus ( neurodermatitis) and lichen planus .- seborrhoeic dermatits – initial or allergic contact dermatitis – discoid lupus erythematosus – adjunct to systematic steroid therapy in generalised erythroderma . – insect bite reactions .- miliaria (pickly heat ) .-

DOSAGE OF BETNOVATE OINT

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

adults,elderly and children over 1 year , OINTMENT is especially appropriate for dry ,lichenified or scaly lesions . Adults and adolescents : apply a thinly and gently rub in using enough to cover the entire affected area once or twice daily for up to 4 weeks , until improvement occurs , then reduce the frequency of application or change the treatment to a less potent preparation . allow adequate time for absorbtion after each application before applying an emolient . in the more resistant lesions , such as the thickened plaques of psoriasis on elbows and knees , the effect of betnovate can be enhanced , if necessary , by occluding the treatment area with polythene film . overnight occlusion only is usually adequate to bring about a satisfactory response in such lesions , thereafter improvement can usually be maintained by regular application without occlusion . if the condition worsens or does not improve withen 2-4 weeks treatment and diagnosis should be re-evaluated . children : betnovate is contraindicated in children under one year of age. children are more likely to develop local and systemic side effects of topical corticosteroids and, in general , requir shorter courses and less pontent agents than adults care should be taken when using betnovate to ensure the amount applied is the minimum that provides therapeutic benefit , – elderly : clinical studies have not identified differences in responses between the elderlty and younger patients . the greater frequency of decreased hepatic or renal function in the elderly may delay elimintation if systematic absorption occurs . therefore the minimum quantity should be used for the shortest duration to achieve the desired clinical beni=efit . – renal / hepatic impairment : in case of systematic absorption ( when application is over a large surface area for a prolonged period ) metabolism and elimintation may be delyed therfore increasing the risk of systematic toxictly . therefore the minimum quantity should be used for the shortest duration to achieve the desired clinical benefit .

OVER-DOSAGE OF BETNOVATE OINT

symptoms and signs : topically applied betamethasone valerate may be absorped in sufficient amounts to produce systemic effects , acute overdosage is very unlikely to occur , however , in the case of chronicoverdosage or misuse the features of hypercortisolism may occur .

CONTRA-INDICATION OF BETNOVATE OINT

the following conditions should not be treated with BETNOVATE : – untreated cutaneous infections .rosacea – acne vulgaris – perioral dermatitis – pruritus without inflammation -perianal and genital pruritus – perioral dermatitis . BETNOVATE N is contraindicated in dermatoses in infants under one year of age , including dermatitis .

STORAGE OF BETNOVATE OINT

store at temperature not exceeding 30 ° C .
PACK OF BETNOVATE OINT
BETNOVATE ointment is provide in alluminium tubes each of 15 gm
BETNOVATE OINT MANUFACTURED BY
Smithkline Beecham – El -Giza-EGYPT For : Glaxosmithkline Egypt.

https://www.webmd.com/drugs/2/drug-4897-722/betamethasone-valerate-topical/betamethasone-valerate-topical/details

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

Reviews

There are no reviews yet.

Show reviews in all languages (1)

Be the first to review “BETNOVATE OINT”

Your email address will not be published.

Shopping Cart
Don`t copy text!
Scroll to Top